CDC2L6 (Center), 253-285 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CDC2L6 (Center), 253-285 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CDC2L6 (Center), 253-285 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse |
| Isotype | n/a |
| Format | purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 2 |
| Applications | Western Blot (WB), ELISA (EIA), Immunohistochemistry (IHC), Flow Cytometry (FC/FACS) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This CDC2L6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 253-285 amino acids from the Central region of human CDC2L6. CDC2L6 is one of the components of the Mediator coactivator complex. The Mediator complex is a multiprotein complex required for transcriptional activation by DNA binding transcription factors of genes transcribed by RNA polymerase II. The protein encoded by this gene is similar to cyclin-dependent kinase 8 which can also be a component of the Mediator complex. |
| Immunogen | n/a |
| Other Names | [Cyclin-dependent kinase 19; CDC2-related protein kinase 6; Cell division cycle 2-like protein kinase 6; Cell division protein kinase 19; Cyclin-dependent kinase 11; Death-preventing kinase; CDK19; CDC2L6; CDK11; KIAA1028] |
| Gene, Accession # | [CDK19], Gene ID: 23097, NCBI: NP_055891.1, UniProt: Q9BWU1 |
| Catalog # | MBS9213908 |
| Price | $165, $370 |
| Order / More Info | CDC2L6 (Center), 253-285 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Malumbres,M., et.al. Nat. Cell Biol. 11 (11), 1275-1276 (2009) Loyer,P., et.al., J. Biol. Chem. 283 (12), 7721-7732 (2008) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies